News

Jamie Dimon says the next generation will live to 100, GeneDx CEO Katherine Stueland says three factors are needed to achieve ...
Do health care providers and even private companies that collect genetic information have an obligation to warn family ...
Multiple bidders are likely to submit offers for the DNA data bank and other assets of bankrupt genetic-testing firm 23andMe, ...
“My bill, HB 449, creates the crime of genetic theft,” Robbins told members of the Senate Judiciary Committee. The Alabama ...
The secret to tackling one of the United States’ most deadly chronic diseases may reside thousands of miles away in the ...
Linda Nolan's stepson, who was suffering from metastatic throat cancer, has sadly died four months after the singer passed ...
In a groundbreaking European project, over 500 people living with mysterious medical conditions have finally received a ...
Belgium’s breast cancer patients are often left without reimbursed treatments, exposing a growing gap between precision oncology's promise and policy reality.
Genetic testing company Myriad Genetics (NASDAQ:MYGN) in Q1 CY2025, with sales falling 3.1% year on year to $195.9 million.
Learn more about whether Exact Sciences Corporation or Natera, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
"The difference between living or dying can rest on whether or not the doctor knows about a particular condition." ...
As researchers make progress in understanding how Alzheimer's disease develops, there are growing opportunities for healthy ...